Leukemia Clinical Trials

Showing 2501-2520 of 10,987 trials

Allergen Provocations- HCA Children's Hospital

NCT04331522

A prospective study of all allergen provocations performed in children at the Hans Christian Andersen Children's Hospital.

Allergy in Children

Josefine Gradman8,000 participantsStarted Oct 2018

Odense, Odense C, Denmark

RECRUITINGPhase 2

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

NCT06453460

This is a phase 2, prospective cohort clinical trial evaluating the utilization of CMV T Cell Immunity Panel (CMV-TCIP) assay to guide the duration of primary CMV prophylaxis in CMV-seropositive recipients of allogeneic stem cell transplant or recipients receiving a stem cell graft from a CMV serology positive donor.

CMVAllogeneic Stem Cell Transplantation

University of California, Irvine50 participantsStarted Jun 2024

Orange, California, United States

RECRUITINGPhase 1

Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors

NCT06773507

The goal of this study is to learn if BC008-1A given 900mg or 1200mg intravenously once every 3 weeks is safe and effective to treat patients with advanced esophageal cancer or advanced non-small cell lung cancer. It will also learn about the safety and pharmacokinetics of BC008-1A.

Advanced Esophageal CancersAdvanced Non-small Cell Lung Cancer (NSCLC)

Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.80 participantsStarted May 2025

Tianjin, China

Allergen Provocations- HCA Children's Hospital

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors

Related Searches

A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)

Arterial Pressure Derived Dynamic Parameters to Detect Preload Responsiveness in Mechanically Ventilated Patients Under Spontaneous Mode

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

Durvalumab as Consolidation for Patients LS-SCLC

AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

Effects of Omega-3 Supplementation on Exercise Performance, Body Composition, and Appetite Status in Female Athletes

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7